Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT05491941

Assessment for Implementation Methods in Sepsis

Led by Rhode Island Hospital · Updated on 2022-08-08

10000

Participants Needed

1

Research Sites

260 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Since the introduction of sepsis bundles, there have been multiple published trials that have demonstrated a consistent, strong association between implementation of sepsis "bundles" (3-hour bundle) and improved survival. The current proposal is a Hybrid 2, pragmatic, cluster randomized clinical effectiveness/implementation trial evaluating mortality and respiratory failure-based outcomes, in patients admitted to the emergency department with sepsis, comparing the effectiveness of implementation of the hour-1 bundle to 3-hour bundle, while facilitating adherence to both bundles. In addition, 4 distinct sepsis phenotypes will be derived from routine clinical data to identify specific patient phenotypes that allow for a more precision-based application of sepsis bundles in future studies.

CONDITIONS

Official Title

Assessment for Implementation Methods in Sepsis

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adults 18 years or older
  • Patients meet criteria for sepsis within 6 hours of emergency department triage
  • Infection, 2 or more systemic inflammatory response syndrome (SIRS) criteria, and at least one organ dysfunction must occur within 3 hours of each other
Not Eligible

You will not qualify if you...

  • Patients admitted previously to the same hospital for sepsis
  • Pregnant women
  • Transfers from another hospital
  • Patients made comfort care only within 6 hours of emergency department admission
  • Moribund patients

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Rhode Island Hospital

Providence, Rhode Island, United States, 02903

Actively Recruiting

Loading map...

Research Team

M

Mitchell Levy, MD

CONTACT

L

Lori Harmon, RRT, MBA, CPHQ

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here